Vaccines Market

Vaccines Market Expected to Reach $72,129.61 Million by 2031 | CAGR of 6.6%

PORTLAND, OREGON, UNITED STATE, July 29, 2022 /EINPresswire.com/ -- Global Vaccines Market by Technology Type, Indication, End User, and Region: Global Opportunity Analysis and Industry Forecast, 2021–2031, the global Vaccines Market accounted for $38,061.15 Million in 2021, and is expected to reach $72,129.61 Million by 2031, registering a CAGR of 6.6% from 2022 to 2031.

Vaccination was considered as one of the greatest public health achievements in industrialized countries during the 20th century, reducing morbidity and mortality from a broad range of vaccine-preventable diseases. Globally, over 5.9 million deaths are prevented annually through vaccination against nine major infectious diseases, including varicella, diphtheria, tetanus, pertussis, Haemophilus influenzae type b (childhood), hepatitis B, measles, and polio. According to CDC, in Canada, immunization has saved more lives over the past 50 years than any other health intervention

Get Sample Report at: (Flash Sale Tell 20th August 2022):
https://www.alliedmarketresearch.com/request-sample/258

Key Market Players

AstraZeneca Plc.
CSL Limited
Emergent Bio Solutions Inc.
GlaxoSmithKline plc.
Johnson & Johnson
Merck & Co., Inc.
Novavax, Inc.
Pfizer
Sanofi Aventis
Serum Institute of India Pvt. Ltd.

Key Findings Of The Study

On the basis of technology type, the recombinant & conjugate vaccines segment held 40.71% share in the global market in 2021.
On the basis of indication, the pneumococcal disease segment held the largest market share in 2021, and is expected to remain dominant throughout the forecast period.
On the basis of end user, the pediatric vaccines segment held the largest market share in 2021, and is expected to remain dominant throughout the forecast period.
Region wise, North America is expected to experience the highest market share during the forecast period. This was attributed to higher healthcare infrastructure, high adoption rate for vaccine products, and sophisticated healthcare infrastructure.

 Key Market Segments

By Technology Type
Recombinant & Conjugate Vaccines
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Others

By Indication

Pneumococcal Disease
Influenza
Human Papilloma Virus
Meningococcal Disease
Rotavirus
Varicella
Measles, Mumps, & Rubella
Diphtheria, Pertussis, & Tetanus (DTP)
Polio
Hepatitis
Other Indications

Impact of Covid-19 On Vaccines Market (Pre And Post Analysis)

Coronavirus (COVID-19) was discovered in late December in the Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans. After its discovery in Wuhan, the disease has rapidly spread to other parts of the globe. This virus causes various symptoms in a patient; for instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement.

By region, North America accounted for the largest market share in the Vaccines Market in 2021 and is expected to retain its dominance throughout the forecast period. This is primarily attributed to investments made by the key players for various R&D activities as well as launch of new products in the U.S. In addition, extensive research in pharmaceutical and biotechnology companies is further anticipated to stimulate the growth of the vaccine market in North America.

Asia-Pacific witnessed the highest growth rate for the Vaccines Market and is expected to continue this trend throughout the forecast period, which is attributed to high burden of diseases, increase in affordability, and improvements in healthcare access in developing countries such as India and China. The report provides a comprehensive analysis of the key players that operate in the global Vaccine Market.

𝗜𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗲𝗱 𝗶𝗻 𝗣𝗿𝗼𝗰𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁? 𝗩𝗶𝘀𝗶𝘁 𝗛𝗲𝗿𝗲 https://www.alliedmarketresearch.com/purchase-enquiry/258

𝗧𝗿𝗲𝗻𝗱𝗶𝗻𝗴 𝗥𝗲𝗽𝗼𝗿𝘁𝘀 𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆

Menstrual Cup Market

VR In Healthcare Market

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.